Keyphrases
Breast Cancer
100%
DNA Repair
100%
Dual Inhibition
100%
Palbociclib
100%
Resistant Cells
57%
IL6-STAT3
57%
Estrogen Receptor
42%
Tumor Samples
42%
Endocrine Therapy
42%
Cyclin-dependent Kinase 4/6 Inhibitors
28%
Receptor Downregulation
28%
MCF-7
14%
Resistance Mechanisms
14%
Cell Death
14%
Deregulation
14%
Patients with Breast Cancer
14%
T47D
14%
Genome-wide Expression
14%
Acquired Resistance
14%
Patient Samples
14%
Whole Exome Sequencing
14%
Time to Progression
14%
Hormone Receptor-positive
14%
Cyclin-dependent Kinase 6 (CDK6)
14%
PARP Inhibitor (PARPi)
14%
HER2-negative Breast Cancer
14%
Proteomic Analysis
14%
Pathway Alteration
14%
Endocrine Resistance
14%
STAT3 Inhibitor
14%
STAT3 Signaling
14%
DNA Damage Response Pathway
14%
Estrogen Receptor Pathway
14%
Alternative Treatment Strategies
14%
Expression Proteomics
14%
Altered Pathway
14%
DNA Repair Deficiency
14%
Medicine and Dentistry
Breast Cancer
100%
DNA Repair
100%
Palbociclib
100%
Estrogen Receptor
57%
Neoplasm
42%
Hormone Therapy
42%
Cyclin-Dependent Kinase 4
42%
Receptor down Regulation
28%
Biological Marker
14%
Diseases
14%
Cell Line
14%
Cell Death
14%
DNA Damage Response
14%
Hormone Receptor
14%
Exome Sequencing
14%
Poly ADP Ribose Polymerase
14%
MCF-7
14%
Expression Analysis
14%
PARP Inhibitor
14%
Expression Proteomics
14%
Biochemistry, Genetics and Molecular Biology
DNA Repair
100%
STAT3
100%
Estrogen Receptor
57%
Cyclin-Dependent Kinase 4
42%
Poly ADP Ribose Polymerase
28%
Receptor down Regulation
28%
Cell Death
14%
Expression Analysis
14%
DNA Damage Response
14%
Exome Sequencing
14%
Hormone Receptor
14%
Expression Proteomics
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Palbociclib
100%
Estrogen Receptor
57%
Neoplasm
42%
Endocrine Therapy
42%
Cyclin Dependent Kinase 4
42%
Diseases
14%
Biological Marker
14%
Hormone Receptor
14%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
14%